OVERVIEW

Antimicrobial resistance (AMR) poses a serious global public health threat. Without concerted and comprehensive action, it could lead to millions of deaths, with much progress in life expectancy over the last half century undone.

The inaugural Antimicrobial Resistance conference in London in 2019 established the need for greater attention to this public health threat. Now, The Economist is taking the event to Asia. With a population of over four billion people, the continent will prove a lynchpin in the global fight against AMR. Asian food and drug companies, governments, health agencies and universities must play a role in developing new diagnostics and antibiotic solutions, ensure stewardship and rational use, and work to improve public awareness.

Antimicrobial Resistance Summit Asia will explore how AMR could undermine the Sustainable Development Goals (SDGs) in Asia, where past economic success has done so much to drive progress in global development. It will bring together voices from health, food and agricultural sectors to explore AMR under the 'One Health' rubric in which it is best understood - especially in the Asian context.

Save the date! Join key Asia-based opinion leaders from government, industry and academia at The Economist Event’s Antimicrobial Resistance Summit on December 5th in Singapore, as we examine an issue that's gone from concerning scientists and politicians to a priority for regional governments.

@EconomistEvents #EconAMR

Additional details will be posted as soon as information is available.